Ra Medical Systems, Inc. (RMED) |
|
0.594 0.054 (10%)
|
08-17 16:00 |
|
Open: |
0.55 |
Pre. Close: |
0.54 |
|
High:
|
0.594 |
Low:
|
0.52 |
|
Volume:
|
74,500 |
Market Cap:
|
4(M) |
|
|
|
Technical analysis |
as of: 2023-09-29 4:30:04 PM |
|
Short-term rate:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
|
Mid-term rate:
|
 |
| Target: |
Six months: 0.64 One year: 0.7 |
| Support: |
Support1: 0.48 Support2: 0.4 |
| Resistance: |
Resistance1: 0.55 Resistance2: 0.6 |
| Pivot: |
0.55  |
| Moving Average: |
MA(5): 0.54 MA(20): 0.54
MA(100): 0.83 MA(250): 2.41 |
| MACD: |
MACD(12,26): -0.1 Signal(9): -0.1 |
| Stochastic oscillator: |
%K(14,3): 53 %D(3): 60.9 |
| RSI: |
RSI(14): 43.2 |
| 52-week: |
High: 7.75 Low: 0.48 |
| Average Vol(K): |
3-Month: 289 (K) 10-Days: 26 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ RMED ] has closed above bottom band by 20.8%. Bollinger Bands are 67.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 12 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.54 - 0.54 |
0.54 - 0.54 |
|
Low:
|
0.5 - 0.5 |
0.5 - 0.5 |
|
Close:
|
0.53 - 0.53 |
0.53 - 0.54 |
|
Company Description |
|
Ra Medical Systems, Inc., a medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular immune-mediated inflammatory diseases. It offers destruction of arteriosclerotic blockages by laser radiation ablation, a minimally invasive excimer laser and single-use catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. The company sells its products primarily through distributors in the United States. Ra Medical Systems, Inc. was incorporated in 2002 and is headquartered in Carlsbad, California. |
Headline News |
Thu, 17 Aug 2023
Reminder: Ra Medical Systems Announces Name and Ticker ... - Fort Worth Star-Telegram
Mon, 14 Aug 2023
Ra Medical Systems Announces Allowance of New Closure Device Patent - Yahoo Finance
Mon, 07 Aug 2023
Ra Medical Systems Announces Milestone Achievement for Electrophysiology Division - Yahoo Finance
Mon, 31 Jul 2023
Ra Medical Systems Announces Proposed Name and Ticker Symbol Changes - Yahoo Finance
Mon, 24 Jul 2023
Ra Medical sees increasing demand for VIVO mapping system - Mass Device
Mon, 03 Jul 2023
RMED’s Electrophysiology Division Expands International Distribution - Yahoo Finance
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Neutral |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: AMEX |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
0 (M) |
| Shares Float |
0 (M) |
|
% Held by Insiders
|
0 (%) |
|
% Held by Institutions
|
0 (%) |
|
Shares Short
|
0 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
0 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
0 |
|
Return on Assets (ttm)
|
0 |
|
Return on Equity (ttm)
|
0 |
|
Qtrly Rev. Growth
|
0 |
|
Gross Profit (p.s.)
|
0 |
|
Sales Per Share
|
0 |
|
EBITDA (p.s.)
|
0 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
0 (M) |
Stock Valuations |
|
PE Ratio
|
0 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0 |
|
Price to Sales
|
0 |
|
Price to Cash Flow
|
0 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
